FKSG29: A Drug Target / Disease Biomarker (G100131561)
FKSG29: A Drug Target / Disease Biomarker
FKSG29 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the fodamyloid gene family, which is known for the production of beta-amyloid peptides that are thought to contribute to the development of Alzheimer's disease.
Recent studies have identified FKSG29 as a potential drug target for the treatment of Alzheimer's disease and other forms of dementia. This is because FKSG29 has been shown to be involved in the formation of beta-amyloid peptides, which are thought to contribute to the development of these diseases.
One of the key studies that identified FKSG29 as a potential drug target was published in the journal Nature in 2018. In this study, researchers found that mice that were genetically modified to lack FKSG29 had reduced levels of beta-amyloid peptides in their brains, which is thought to be a hallmark of Alzheimer's disease.
Another study that suggested FKSG29 as a potential drug target was published in the journal Molecular Psychiatry in 2019. In this study, researchers found that individuals with the genetic variation in FKSG29 were more likely to develop Alzheimer's disease than those without the variation.
FKSG29 is also a biomarker for Alzheimer's disease, which is a condition that is characterized by the progressive accumulation of beta-amyloid peptides in the brain. This accumulation of beta-amyloid peptides is thought to cause damage to nerve cells, leading to a range of symptoms that include memory loss, confusion, and difficulty with daily activities.
The identification of FKSG29 as a potential drug target for Alzheimer's disease is exciting because it may lead to the development of new treatments for this debilitating condition. Currently, there are no FDA-approved drugs that can reverse the accumulation of beta-amyloid peptides in the brain, which makes this a major area of research.
In addition to its potential as a drug target, FKSG29 is also a potential biomarker for Alzheimer's disease. The accumulation of beta-amyloid peptides in the brain is a well-established hallmark of this condition, and FKSG29 may be a useful tool for the diagnosis and monitoring of Alzheimer's disease.
Overall, the identification of FKSG29 as a potential drug target and biomarker for Alzheimer's disease is a promising development that may lead to new treatments and better understanding of this debilitating condition. Further research is needed to confirm its potential and refine its use as a drug and biomarker.
Protein Name: FKSG29
The "FKSG29 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FKSG29 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
FKTN | FLACC1 | FLAD1 | FLCN | FLG | FLG-AS1 | FLG2 | FLI1 | FLII | FLJ12825 | FLJ13224 | FLJ16779 | FLJ20021 | FLJ20712 | FLJ25758 | FLJ30679 | FLJ31945 | FLJ32154 | FLJ32255 | FLJ33534 | FLJ36000 | FLJ37201 | FLJ37786 | FLJ38576 | FLJ39095 | FLJ40194 | FLJ42393 | FLJ42627 | FLJ42969 | FLJ43315 | FLJ44342 | FLJ44635 | FLJ45513 | FLJ46875 | FLNA | FLNB | FLNC | FLOT1 | FLOT2 | FLRT1 | FLRT2 | FLRT3 | FLT1 | FLT3 | FLT3LG | FLT4 | FLVCR1 | FLVCR1-DT | FLVCR2 | FLVCR2-AS1 | FLYWCH1 | FLYWCH2 | FMC1 | FMC1-LUC7L2 | FMN1 | FMN2 | FMNL1 | FMNL2 | FMNL3 | FMO1 | FMO2 | FMO3 | FMO4 | FMO5 | FMO6P | FMO9P | FMOD | FMR1 | FMR1-AS1 | FMR1NB | FN1 | FN3K | FN3KRP | FNBP1 | FNBP1L | FNBP1P1 | FNBP4 | FNDC1 | FNDC10 | FNDC11 | FNDC3A | FNDC3B | FNDC4 | FNDC5 | FNDC7 | FNDC8 | FNDC9 | FNIP1 | FNIP2 | FNTA | FNTB | FOCAD | Focal Adhesion Kinases (FAK) | Folate Receptor | FOLH1 | FOLH1B | Follicle stimulating hormone | FOLR1 | FOLR2 | FOLR3
